Pall T. Onundarson: The 3-Decade Journey of Ultrasound-Enhanced Fibrinolysis in PE
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, shared a post on LinkedIn about a recent article by Kenneth Rosenfield et al, published in NEJM, adding:
”Interesting how late the fruits of research may bloom.
Back in 1990–1991, during my research fellowship at the University of Rochester Medical Center (Strong Memorial Hospital), I performed in vitro experiments that were probably the first to show that ultrasound could enhance fibrinolysis in vitro, likely by improving the transport of enzymes and/or plasminogen into clots.
Since then, numerous studies have been published, including clinical investigations.
Now, in the May 28 2026 issue of the NEJM, a clinical trial has been reported that may prove particularly significant:
‘In this trial, ultrasound-facilitated, catheter directed fibrinolysis plus anticoagulation led to a lower risk of the composite of pulmonary embolism–related death, cardiopulmonary decompensation or collapse, or symptomatic recurrence of pulmonary embolism within 7 days than anticoagulation alone in patients with acute, intermediate-risk pulmonary embolism. No apparent differences between the two treatment groups with regard to major bleeding complications were observed’.”
Title: Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism
Authors: Kenneth Rosenfield, Frederikus A. Klok, Gregory Piazza, Andrew S.P. Sharp, Fionnuala Ní Áinle, Michael R. Jaff, Stefano Barco, Samuel Z. Goldhaber, Nils Kucher, Irene M. Lang, Irene Schmidtmann, Keith M. Sterling, Aleksander Araszkiewicz, Vishal Arora, Rafael Cires-Drouet, John Coghlan, Lukas Hobohm, Wulf D. Ito, Kurt Jacobson, Christoph Kaiser, Grzegorz Kopec, Kristin Marx, Samuel McElwee, Nicolas Meneveau, Peter Monteleone, Jose M. Montero-Cabezas, Christoph B. Olivier, John Park, Marek Roik, Rahul Sakhuja, Andi Tego, Markus Theurl, Gautam Visveswaran, Jan Albert Vos, Michael N. Young, Federico M. Asch, Stavros V. Konstantinides

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 14, 2026, 18:20Yuria Ito: Does an MCV Below 100 Mean There Is No Vitamin B12 Deficiency?
-
Oct 14, 2026, 18:08Micheal Avoseh: Nanoparticle Research for Venous Thrombosis
-
Oct 14, 2026, 18:00A Decade of Symptoms Before a Rare Disease Diagnosis – ITP Support Association
-
Oct 14, 2026, 17:52David McIntosh: The Global Blood Shortage and the Need for Sustainable Donor Recruitment
-
Oct 14, 2026, 17:41Emmanuel J Favaloro։ October 13 is World Thrombosis Day
-
Oct 14, 2026, 17:24EHC ERIN Webinar on Fibrinogen Disorders
-
Oct 14, 2026, 16:50Peter Kouides: The Role of Multidisciplinary Networks in Women’s Hematologic Care
-
Oct 14, 2026, 16:35Thaís Leonel: Analytical Consistency as a Foundation for Evidence-Based Thrombosis Management
-
Oct 14, 2026, 16:28Christina Yiangou: Presenting the HemaFAIR Project at ASCAT 2026 in London